| Literature DB >> 33437183 |
Kamil Torres1, Łukasz Pietrzyk1, Marta Denisow-Pietrzyk1, Sebastian Radej2, Andrzej ChroŚcicki3, Anna Torres2.
Abstract
INTRODUCTION: Surgical intervention affects local and systemic immune responses, especially in obese individuals. Many studies have attempted to evaluate immunological response to surgical trauma. Surgery changes the quantity and phenotype of circulating blood dendritic cells (DCs), including a decrease of total DCs post-operatively. The study aimed to evaluate the percentage and changes of myeloid, lymphoid DCs, and myeloid to lymphoid DCs ratio in obese and normal weight patients undergoing laparoscopy.Entities:
Keywords: dendritic cells; immune system; laparoscopy; obesity; surgery
Year: 2020 PMID: 33437183 PMCID: PMC7789999 DOI: 10.5114/ceji.2020.101255
Source DB: PubMed Journal: Cent Eur J Immunol ISSN: 1426-3912 Impact factor: 2.085
Percentages of myeloid (BDCA-1+ and CD19–) and lymphoid (BDCA-2+ and CD123+) cells, and the myeloid to lymphoid cells ratio (BDCA-1+ and CD19–/BDCA-2+ and CD123+) in peripheral blood of patients in both studied groups at three time points
| Parameter | Group | ||||
|---|---|---|---|---|---|
| N | O | ||||
| Median (%) | Min-max (%) | Median (%) | Min-max (%) | ||
| BDCA-1+/CD19– pre-OP | 0.18 | 0.02-0.31 | 0.17 | 0.09-0.35 | 0.484 |
| BDCA-1+/CD19– post-OP 24 h | 0.20 | 0.01-0.40 | 0.20 | 0.06-0.33 | 0.969 |
| BDCA-1+/CD19– post-OP 48 h | 0.22 | 0.07-0.49 | 0.24 | 0.12-0.43 | 0.388 |
| BDCA-2+/CD123+ pre-OP | 0.16 | 0.02-0.27 | 0.16 | 0.05-0.33 | 0.761 |
| BDCA-2+/CD123+ post-OP 24 h | 0.19 | 0.06-0.31 | 0.22 | 0.05-0.41 | 0.421 |
| BDCA-2+/CD123+ post-OP 48 h | 0.17 | 0.08-0.37 | 0.27 | 0.09-0.54 | 0.171 |
| BDCA-1+/CD19– /BDCA-2+/CD123+ pre-OP | 1.20 | 0.67-2.42 | 1.18 | 0.45-4.78 | 0.968 |
| BDCA-1+/CD19– /BDCA-2+/CD123+ post-OP 24 h | 1.14 | 0.14-1.91 | 0.98 | 0.38-2.53 | 0.280 |
| BDCA-1+/CD19– /BDCA-2+/CD123+ post-OP 48 h | 1.27 | 0.62-2.41 | 1.00 | 0.41-2.71 | 0.031 |
Changes of the percentage of myeloid (BDCA-1+ and CD19–) and lymphoid (BDCA-2+ and CD123+) cells, and the myeloid to lymphoid cells ratio (BDCA-1+ and CD19–/BDCA-2+ and CD123+) in peripheral blood of patients in both studied groups at three time periods
| Parameter | Group | |
|---|---|---|
| N | O | |
| BDCA-1+/CD19– time period 0-24 h | ↔ (5.27%) | ↔ (10.51%) |
| BDCA-1+/CD19– time period 24-48 h | ↑ (14.79%) | ↑ (28.10%) |
| BDCA-1+/CD19– time period 0-48 h | ↑ (19.98%) | ↑ (33.31%) |
| BDCA-2+/CD123+ time period 0-24 h | ↑ (15.36%) | ↑ (26.30%) |
| BDCA-2+/CD123+ time period 24-48 h | ↔ (-9.50%)* | ↑ (18.40%)* |
| BDCA-2+/CD123+ time period 0-48 h | ↔ (5.54%)* | ↑ (47.60%)* |
| BDCA-1+/CD19–/BDCA-2+/CD123+ | ↔ (-4.90%) | ↓ (-5.04%) |
| BDCA-1+/CD19–/BDCA-2+/CD123+ | ↑ (12.77%) | ↔ (4.91%) |
| BDCA-1+/CD19–/BDCA-2+/CD123+ | ↔ (4.90%) | ↔ (-4.44%) |
↑ statistically significant increase, ↓ statistically significant decrease, ↔ no statistically significant change, * statistically significant change in group O compared to group N